A multicenter study to assess the cholesterol lowering level of switching to an investigational drug compared to doubling the dose of an investigational drug in patients with hypercholesterolemia and atherosclerotic or coronary vascular disease.

Trial Profile

A multicenter study to assess the cholesterol lowering level of switching to an investigational drug compared to doubling the dose of an investigational drug in patients with hypercholesterolemia and atherosclerotic or coronary vascular disease.

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Apr 2017

At a glance

  • Drugs Ezetimibe/simvastatin (Primary) ; Atorvastatin
  • Indications Atherosclerosis; Coronary disorders; Hypercholesterolaemia
  • Focus Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 22 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top